RightFit Trial Directory

Type 2 Diabetes clinical trials in St Louis, MO

11 recruiting type 2 diabetes studies with a site in St Louis, MO.

All trials in St Louis, MO · All Type 2 Diabetes trials

RecruitingPhase 3NCT07654374

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Chesterfield, MO · City of Saint Peters, MO · Hazelwood, MO · +71 more sites

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Jefferson City, MO · Kansas City, MO · St Louis, MO · +205 more sites

RecruitingPhase 3NCT07667803

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Sponsor: AstraZeneca

Kansas City, MO · St Louis, MO · +54 more sites

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Chesterfield, MO · St Louis, MO · +97 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

Kansas City, MO · St Louis, MO · +51 more sites

RecruitingPhase 1 / Phase 2NCT05267626

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Sponsor: Aulos Bioscience, Inc.

St Louis, MO · +9 more sites

RecruitingPhase 3NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Sponsor: Ascletis Pharma (China) Co., Limited

Columbia, MO · St Louis, MO · +82 more sites

RecruitingPhase 3NCT07662044

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Kansas City, MO · St Louis, MO · +25 more sites

RecruitingNot applicableNCT06830096

Role of KATP Channel Loss in Type 2 Diabetes

Sponsor: Washington University School of Medicine

St Louis, MO

RecruitingPhase not listedNCT05277558

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Sponsor: Washington University School of Medicine

St Louis, MO · +1 more sites

Not yet recruitingPhase 3NCT07881458

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Sponsor: Eli Lilly and Company

St Louis, MO · +24 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.